Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Mathalon

Showing results (181-190 of 435) with videos related to

Pageof 44
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 23, 2020
A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressantsChadi G Abdallah, Kyung-Heup Ahn, Lynnette A Averill, et al.
Schizophrenia Research|June 25, 2018
A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDSAdrian Preda, Dana D Nguyen, Juan R Bustillo, et al.
Frontiers in Psychiatry|August 10, 2019
Altered Domain Functional Network Connectivity Strength and Randomness in SchizophreniaVictor M Vergara, Eswar Damaraju, Jessica A Turner, et al.
Schizophrenia Research|July 30, 2025
Victimization and engagement with the legal system among individuals at clinical high risk (CHR) for psychosisAshley Du, Leda Kennedy, Jean Addington, et al.
Schizophrenia Bulletin|August 26, 2025
Predictors and Moderators of Long-Term Outcome of Persons at Clinical High Risk for Psychosis: Methods and Preliminary DataKristin S Cadenhead, Leda Kennedy, Heline Mirzakhanian, et al.
Journal of Affective Disorders|May 7, 2025
Trajectories of positive symptoms and suicidality in individuals at clinical high risk for psychosisWisteria Deng, Christian MacNutt, Jean Addington, et al.
Early Intervention in Psychiatry|June 24, 2026
Exploring Group Differences in Attenuated Symptoms and Functioning Between Clinical High-Risk Individuals With and Without Posttraumatic Stress DisorderDanielle Pham, Leda Kennedy, Jean Addington, et al.
Psychological Medicine|February 11, 2022
Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomesWisteria Deng, Jean Addington, Carrie E Bearden, et al.
Neuroimage. Clinical|March 29, 2019
Group ICA for identifying biomarkers in schizophrenia: 'Adaptive' networks via spatially constrained ICA show more sensitivity to group differences than spatio-temporal regressionMustafa S Salman, Yuhui Du, Dongdong Lin, et al.
Frontiers in Neuroscience|August 22, 2013
A multi-site resting state fMRI study on the amplitude of low frequency fluctuations in schizophreniaJessica A Turner, Eswar Damaraju, Theo G M van Erp, et al.
Pageof 44

Showing results (181-190 of 435) with videos related to

Sort By:
Pageof 44
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 23, 2020
A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressantsChadi G Abdallah, Kyung-Heup Ahn, Lynnette A Averill, et al.
Schizophrenia Research|June 25, 2018
A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDSAdrian Preda, Dana D Nguyen, Juan R Bustillo, et al.
Frontiers in Psychiatry|August 10, 2019
Altered Domain Functional Network Connectivity Strength and Randomness in SchizophreniaVictor M Vergara, Eswar Damaraju, Jessica A Turner, et al.
Schizophrenia Research|July 30, 2025
Victimization and engagement with the legal system among individuals at clinical high risk (CHR) for psychosisAshley Du, Leda Kennedy, Jean Addington, et al.
Schizophrenia Bulletin|August 26, 2025
Predictors and Moderators of Long-Term Outcome of Persons at Clinical High Risk for Psychosis: Methods and Preliminary DataKristin S Cadenhead, Leda Kennedy, Heline Mirzakhanian, et al.
Journal of Affective Disorders|May 7, 2025
Trajectories of positive symptoms and suicidality in individuals at clinical high risk for psychosisWisteria Deng, Christian MacNutt, Jean Addington, et al.
Early Intervention in Psychiatry|June 24, 2026
Exploring Group Differences in Attenuated Symptoms and Functioning Between Clinical High-Risk Individuals With and Without Posttraumatic Stress DisorderDanielle Pham, Leda Kennedy, Jean Addington, et al.
Psychological Medicine|February 11, 2022
Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomesWisteria Deng, Jean Addington, Carrie E Bearden, et al.
Neuroimage. Clinical|March 29, 2019
Group ICA for identifying biomarkers in schizophrenia: 'Adaptive' networks via spatially constrained ICA show more sensitivity to group differences than spatio-temporal regressionMustafa S Salman, Yuhui Du, Dongdong Lin, et al.
Frontiers in Neuroscience|August 22, 2013
A multi-site resting state fMRI study on the amplitude of low frequency fluctuations in schizophreniaJessica A Turner, Eswar Damaraju, Theo G M van Erp, et al.
Pageof 44